Research


September 3, 2020

UAMS Researchers Awarded $11.4 Million Grant to Continue Study of Cancer Therapy Side Effects

Ben Boulden

The four new COBRE researchers are, left to right, Amanda Stolarz, Ping-Ching Hsu, Brendan Frett and Caroline Schinke.

LITTLE ROCK — Led by Marjan Boerma, Ph.D., a team of University of Arkansas for Medical Sciences (UAMS) researchers has received a five-year $11.4 million grant to continue research into the side effects of cancer therapies, including radiation and chemotherapies. The Centers for Biomedical Research Excellence (COBRE), a program of the National Institute of General…


September 2, 2020

UAMS Lung Cancer Researcher Contributes to Publication of Validation Protocols for Liquid Biopsy to Detect Cancer

Susan Van Dusen

Donald J. Johann, M.D.

Donald J. Johann, M.D., a lung cancer researcher at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), played an integral role in the publication of research related to liquid biopsy tests, or blood tests, for cancer.


September 1, 2020

UAMS’ Alan Tackett, Ph.D., Named to NIH Mechanisms of Cancer Therapeutics Study Section

Susan Van Dusen

Alan Tackett, PhD

Alan Tackett, Ph.D., was recently named a member of the National Institutes of Health (NIH) Mechanisms of Cancer Therapeutics-1 (MCT1) Study Section, one of the major review boards for evaluation of cancer research by the NIH Center for Scientific Review.


August 26, 2020

$10.6 Million Federal Grant to Expand National Proteomics Resource at UAMS

Susan Van Dusen

Alan Tackett, PhD

A $10.6 million grant from the National Institutes of Health (NIH) will allow the University of Arkansas for Medical Sciences (UAMS) to greatly expand its proteomics resource. This grant will establish the IDeA National Resource for Quantitative Proteomics as the first NIH National Resource in Arkansas, which will serve biomedical researchers across the entire nation.


August 24, 2020

UAMS Researchers See 43% Funding Increase in FY2020

David Robinson

Shuk-Mei Ho, Ph.D., UAMS vice chancellor for Research and Innovation, said new research approaches have helped spur funding growth.

LITTLE ROCK – The University of Arkansas for Medical Sciences (UAMS) and its affiliate research institutions saw research funding grow by 43% this past year, with $158.1 million in grants by the end of the fiscal year, June 30. The bulk of the funding is from the National Institutes of Health (NIH) and other federal…


July 24, 2020

Grant Gives UAMS Physician-Scientist Access to Gene Analysis Software

Susan Van Dusen

Dr. Analiz Rodriguez

New grant funding will assist UAMS physician-scientist Analiz Rodriguez, M.D., Ph.D., in identifying more effective therapies for patients whose cancer has spread to their brain.


July 23, 2020

Fenghuang “Frank” Zhan, M.D., Ph.D., Awarded Nearly $3.14 Million to Further Myeloma Research

Linda Haymes

Fenghuang “Frank” Zhan, M.D., Ph.D., Myeloma Center research director at the University of Arkansas for Medical Sciences (UAMS), has received two grants totaling almost $3.14 million to study the molecular genetics and drug resistance of multiple myeloma, the second-most common blood-related cancer.

LITTLE ROCK — Fenghuang “Frank” Zhan, M.D., Ph.D., Myeloma Center research director at the University of Arkansas for Medical Sciences (UAMS), has received two grants totaling almost $3.14 million to study the molecular genetics and drug resistance of multiple myeloma, the second-most common blood-related cancer. One grant from the U.S. Department of Defense provides $1.4…


July 21, 2020

National Cancer Database at UAMS Becomes U.S. Storehouse for COVID-19 Images

David Robinson

A Chest Radiograph (left) and Computed Tomography (CT) image (right) of the same COVID-19 patient taken one day apart. These UAMS images, now publicly available in the national Cancer Imaging Archive, show COVID-19 lung infection similar to pneumonia. Medical experts refer to the appearance as ground glass opacities, a haziness overlying the lung that is common with COVID-19 patients.

LITTLE ROCK — A national database for patient cancer images at UAMS will become the storage site for COVID-19 clinical images from across the United States and around the globe, including chest x-rays and CT scans of the body. This week, UAMS also became the first research institution to contribute de-identified images of COVID-19 to…


June 25, 2020

UAMS Cancer Institute Joins KIYATEC Clinical Study of Test to Predict Pre-Treatment, Patient-Specific Response to Ovarian Cancer Drugs

Susan Van Dusen

Michael Birrer, MD, PhD

KIYATEC, Inc. today announced that the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) has joined the growing roster of institutions participating in its 3D-PREDICT clinical study to validate the company’s test as a patient-specific predictor of response to recommended drug therapies for patients with ovarian cancer.


June 22, 2020

UAMS Part of International Effort to Build AI Platform for Cancer Research

David Robinson

Fred Prior, Ph.D., has a leading role in international effort to apply artificial intelligence to cancer research.

LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) will have a key role in a major international effort using artificial intelligence (AI) to teach computers at local research centers how to recognize cancer. UAMS has received a four-year grant of $894,074 as part of EuCanImage, a nearly $9 million cancer research project…



Previous page Next page